These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18055976)

  • 21. Systemic mastocytosis masquerading as metastatic breast carcinoma.
    Huber MR; Ayalew T
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):750-1. PubMed ID: 16163260
    [No Abstract]   [Full Text] [Related]  

  • 22. Survey of aspirin administration in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):122-4. PubMed ID: 19429499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Systemic mastocytosis].
    Sökler M; Kanz L
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():96. PubMed ID: 16379260
    [No Abstract]   [Full Text] [Related]  

  • 24. Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis.
    Nedoszytko B; Niedoszytko M; Lange M; van Doormaal J; Gleń J; Zabłotna M; Renke J; Vales A; Buljubasic F; Jassem E; Roszkiewicz J; Valent P
    Allergy; 2009 Feb; 64(2):287-94. PubMed ID: 19178408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interesting biopsy case of a malignant soft tissue tumor of the femur].
    Okada H; Nakayama H; Umisa H; Yokoyama Y; Ito I
    Rinsho Byori; 1969 Feb; 17(2):156-7. PubMed ID: 5814341
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Low-grade fibromyxoid sarcoma arising in the big toe.
    Cabibi D
    Pathol Int; 2007 Jul; 57(7):458; author reply 459-60. PubMed ID: 17587247
    [No Abstract]   [Full Text] [Related]  

  • 27. [Molecular diagnosis of routine sarcomas].
    Coindre JM
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S64-5. PubMed ID: 18984305
    [No Abstract]   [Full Text] [Related]  

  • 28. Dasatinib therapy for systemic mastocytosis: four cases.
    Purtill D; Cooney J; Sinniah R; Carnley B; Cull G; Augustson B; Cannell P
    Eur J Haematol; 2008 May; 80(5):456-8. PubMed ID: 18284618
    [No Abstract]   [Full Text] [Related]  

  • 29. [Melanocytic choroidal changes in mastocytosis].
    Michel B; Lang GK
    Klin Monbl Augenheilkd; 2009 Mar; 226(3):193-4. PubMed ID: 19294593
    [No Abstract]   [Full Text] [Related]  

  • 30. Lenalidomide therapy in systemic mastocytosis.
    Kluin-Nelemans HC; Ferenc V; van Doormaal JJ; van Iperen C; Peters WG; Akin C; Valent P
    Leuk Res; 2009 Mar; 33(3):e19-22. PubMed ID: 18644623
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic mastocytosis with an associated hematological neoplasm masquerading as overt primary myelofibrosis.
    Xu RZ; Xu Z
    Blood; 2018 Dec; 132(24):2613. PubMed ID: 30545894
    [No Abstract]   [Full Text] [Related]  

  • 32. New aspects of liver abnormalities as part of the systemic mast cell activation syndrome.
    Alfter K; von Kügelgen I; Haenisch B; Frieling T; Hülsdonk A; Haars U; Rolfs A; Noe G; Kolck UW; Homann J; Molderings GJ
    Liver Int; 2009 Feb; 29(2):181-6. PubMed ID: 18662284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD30 expression in cutaneous lesions of systemic mastocytosis: clinical, biological and histopathological analysis of 27 patients.
    Poirier E; Fraitag S; Tezenas du Montcel S; Moguelet P; Charlotte F; Lortholary O; Hermine O; Canioni D; Barete S;
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):e344-e347. PubMed ID: 30989735
    [No Abstract]   [Full Text] [Related]  

  • 34. Review.
    Horny HP
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):752. PubMed ID: 16163261
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood undifferentiated embryonal liver sarcoma: clinical features and immunohistochemistry analysis.
    Wei ZG; Tang LF; Chen ZM; Tang HF; Li MJ
    J Pediatr Surg; 2008 Oct; 43(10):1912-9. PubMed ID: 18926232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.
    van Daele PL; Beukenkamp BS; Geertsma-Kleinekoort WM; Valk PJ; van Laar JA; van Hagen PM; van der Velden VH
    Neth J Med; 2009 Apr; 67(4):142-6. PubMed ID: 19581658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophil phagocytosis in advanced systemic mastocytosis with eosinophilia.
    Morales-Camacho RM; Villanueva-Herraiz S; Prats-Martín C; Borrero JJ; Bernal R; Vargas MT
    Br J Haematol; 2018 Jun; 181(5):578. PubMed ID: 29602231
    [No Abstract]   [Full Text] [Related]  

  • 39. Beneficial effects of JAK inhibitor therapy in Systemic Mastocytosis.
    Dowse R; Ibrahim M; McLornan DP; Moonim MT; Harrison CN; Radia DH
    Br J Haematol; 2017 Jan; 176(2):324-327. PubMed ID: 26847591
    [No Abstract]   [Full Text] [Related]  

  • 40. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
    Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
    Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.